Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

Credit: Reese Pharmaceutical. ColoTest is designed to detect blood in stool, which may be an early indication for colorectal cancer, diverticulitis, gastrointestinal disorders, colitis or polyps.

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...

These are the FDA-approved options to test for prostate, colorectal, and cervical cancer.

Stool-based tests for colorectal cancer (CRC) screening show no significant difference in detecting advanced neoplasia overall, but for advanced serrated lesions specifically, the multitarget stool ...

Individuals who do not complete followup colonoscopy after a positive stool test could be at substantially higher risk for ...

Please provide your email address to receive an email when new articles are posted on . The COVID-19 pandemic created new barriers for colorectal cancer screening. However, fecal occult blood tests ...

Colorectal cancer screening can cut a person's risk of dying from the disease in half, yet about 40 percent of those who should get tested don't do it. Subscribe to read this story ad-free Get ...